Farms.com Home   Ag Industry News

OMAFRA launches Pollinator Health Action Plan

Plan includes restoring one million acres of pollinator habitat

By Diego Flammini
Assistant Editor, North American Content
Farms.com

OMAFRA launched its new Pollinator Health Action Plan to help bees and other insects continue to pollinate crops that eventually end up in grocery stores across the province.

The initiative consists of a variety of actions designed to help pollinators thrive, including:

  • Restoring and protecting one million acres of pollinator habitat across Ontario,
  • Collecting data to monitor managed honey bee colonies and wild pollinators,
  • Collecting data to track neonicotinoid levels,
  • And launching a special research call ($1 million) to fund new research addressing key knowledge gaps related to pollinator health.

“The Pollinator Health Action Plan is part of our government’s plan to ensure a sustainable local food supply, resilient natural habitats and a strong economy,” Ontario Minister of Agriculture Jeff Leal said in a release. “Our plan builds on changes already being made by the agriculture sector to support pollinator health.”

 

Those changes include Ontario becoming the first area in North America intending to reduce the number of corn and soybean acres planted with neonicotinoid-treated seeds by 80 per cent by 2017.

“Pollinators, including honey bees, are in decline,” Glen Murray, Ontario Minister of the Environment and Climate Change, said in the release. “Ontario is committed to reversing this trend. While we have made strides by restricting the use of neonicotinoids harmful to bees and other beneficial insects, we all still have more to do to protect pollinators.”


Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.